Ginkgo Bioworks Holdings, Inc. (DNA) Balance Sheet
As of 2026-06-30 (10-Q), Ginkgo Bioworks Holdings, Inc. (DNA) reported total assets of $990.0M, total liabilities of $569.8M and shareholders' equity of $420.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $84.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DNAGinkgo Bioworks Holdings, Inc.Follow DNA — free
—
Price chart with a free account
- Market cap
- 672.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.55 | 1.32 | 0.94 | 0.56 | 0.17 | 0.08 | |
| Short-term investments | — | — | — | 0.00 | 0.26 | — | |
| Receivables | 0.13 | 0.08 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Inventory | 0.00 | 0.00 | 0.00 | — | — | — | |
| Current assets | 1.72 | 1.45 | 1.00 | 0.60 | 0.47 | 0.33 | |
| Total assets | 2.07 | 2.54 | 1.67 | 1.38 | 1.12 | 0.99 | |
| Current liabilities | 0.13 | 0.17 | 0.16 | 0.11 | 0.10 | 0.07 | |
| Total liabilities | 0.50 | 0.80 | 0.57 | 0.66 | 0.61 | 0.57 | |
| Shareholders' equity | 1.51 | 1.74 | 1.10 | 0.72 | 0.51 | 0.42 |
USD billions · SEC XBRL
Ginkgo Bioworks Holdings, Inc. — questions
- How much cash does Ginkgo Bioworks Holdings, Inc. have?
- $84.5M in cash and cash equivalents as of 2026-06-30.
- What are Ginkgo Bioworks Holdings, Inc.'s total assets?
- $990.0M as of 2026-06-30.
- What is Ginkgo Bioworks Holdings, Inc.'s shareholders' equity?
- $420.3M as of 2026-06-30.
Every figure on this page comes from Ginkgo Bioworks Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.